Intellia Therapeutics Inc (NTLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$8.88

Buy

$8.92

arrow-down$-0.33 (-3.62%)

Prices updated at 17 Dec 2025, 13:16 EST

Prices minimum 15 mins delay

Prices in USD

Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.

NASDAQ

-1.81%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$9.55 - $8.78
	$28.25 - $5.90
	-
	1,018.15m
	-
	-
	47,677
	1.36
	5,013,233.08
	3.23
	102.03m
	US45826J1051
	-4.25
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.